1. People's Republic of China Stocks

  2. •

    Healthcare

  3. •

    Medical - Specialties
Kontour (Xi'an) Medical Technology Co., Ltd. Class A

Kontour (Xi'an) Medical Technology Co., Ltd. Class A

688314.SS
Kontour (Xi'an) Medical Technology Co., Ltd. Class ACN flagShanghai Stock Exchange
32.87
CNY
-1.47
- -
2.67BMarket Cap

Total Valuation

Kontour (Xi'an) Medical Technology Co., Ltd. Class A carries a market capitalization of 2.67B, placing it among publicly traded companies globally. Its enterprise value stands at 2.13B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap2.67B
Enterprise Value2.13B

Share Statistics

Kontour (Xi'an) Medical Technology Co., Ltd. Class A currently has 81.24M shares outstanding.

Shares Outstanding81.24M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

Kontour (Xi'an) Medical Technology Co., Ltd. Class A trades at a trailing price-to-earnings ratio of 26.17. The price-to-sales ratio is 7.30, and the price-to-book ratio stands at 7.68.

PE Ratio26.17
PS Ratio7.30
PB Ratio7.68
P/TBV Ratio3.82
P/FCF Ratio58.27
P/OCF RatioN/A

Enterprise Valuation

On an enterprise value basis, Kontour (Xi'an) Medical Technology Co., Ltd. Class A trades at an EV/EBITDA multiple of 17.05 and an EV/FCF ratio of 48.18. The EV/Sales ratio of 6.29 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 17.05 provides insight into valuation relative to core operating earnings.

EV / Sales6.29
EV / EBITDA17.05
EV / EBIT17.05
EV / FCF48.18

Financial Position

Kontour (Xi'an) Medical Technology Co., Ltd. Class A maintains a current ratio of 5.35, meaning it holds 5.3x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 6.54, indicating elevated leverage, while an interest coverage ratio of 58.32 demonstrates strong ability to service its debt obligations.

Current Ratio5.35
Quick Ratio4.81
Debt / Equity6.54
Debt / EBITDA0.36
Interest Coverage58.32

Financial Efficiency

Kontour (Xi'an) Medical Technology Co., Ltd. Class A posts a return on equity of 31.99 and a return on invested capital of 15.01.

Return on Equity (ROE)31.99
Return on Assets (ROA)12.70
Return on Invested Capital (ROIC)15.01
Return on Capital Employed (ROCE)28.62
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover2.82

Taxes

Over the trailing twelve months, Kontour (Xi'an) Medical Technology Co., Ltd. Class A has paid 18.21M in income taxes, reflecting an effective tax rate of 16.25.

Income Tax18.21M
Effective Tax Rate16.25

Stock Price Statistics

Kontour (Xi'an) Medical Technology Co., Ltd. Class A's stock has declined approximately -1.11312% over the past 52 weeks. The 50-day moving average sits at 40.58, while the 200-day moving average is 38.88.

Beta (5Y)N/A
52-Week Price Change-1.11312%
50-Day Moving Average40.58
200-Day Moving Average38.88
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Kontour (Xi'an) Medical Technology Co., Ltd. Class A generated 338.92M in revenue and converted that into 94.61M in net income, yielding earnings per share of 1.17. EBITDA reached 125.15M, while operating income came in at 125.15M.

Revenue338.92M
Gross Profit268.72M
Operating Income125.15M
Pretax Income112.09M
Net Income94.61M
EBITDA125.15M
EBIT125.15M
Earnings Per Share (EPS)1.17

Balance Sheet

Kontour (Xi'an) Medical Technology Co., Ltd. Class A holds 388.61M in cash and equivalents against 44.63M in total debt, resulting in a net debt position of -318.61M. Total book value stands at 322.45M, with working capital of 351.75M providing operational flexibility.

Cash & Cash Equivalents388.61M
Total Debt44.63M
Net Debt-318.61M
Equity (Book Value)322.45M
Book Value Per Share4.02
Working Capital351.75M

Cash Flow

After subtracting -42.48M in capital expenditures, free cash flow totaled -42.48M - equivalent to -0.53 per share.

Operating Cash FlowN/A
Capital Expenditures-42.48M
Free Cash Flow-42.48M
FCF Per Share-0.53

Margins

Kontour (Xi'an) Medical Technology Co., Ltd. Class A operates with a gross margin of 79.29, reflecting its pricing power and cost economics. The operating margin of 36.92 and net profit margin of 27.91 provide insight into operational efficiency.

Gross Margin79.29
Operating Margin36.92
Pretax Margin33.07
Profit Margin27.91
EBITDA Margin36.92

Dividends & Yields

The company's payout ratio of 33.53 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share0.39
Dividend YieldN/A
Payout Ratio33.53
Shareholder Yield1.39
FCF Yield1.72

Stock Splits

Kontour (Xi'an) Medical Technology Co., Ltd. Class A's most recent stock split took place on April 27, 2023 with a 5:7 split ratio.

Last Split Date4/27/2023
Split Ratio5:7

Scores

Kontour (Xi'an) Medical Technology Co., Ltd. Class A posts an Altman Z-Score of 17.60, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score17.60